The Gap Between Prescription and Practice: Adrenaline Autoinjector Carriage in an Australian Cohort Authors: Jason Chun Lao, Yi Tong Vincent Aw, Reina Zaragoza, Jamma Li, Therese Boyle, Suran L Fernando, Shruti Swamy Published: 2026 ABSTRACT Summary In this Australian cohort, 45% of 152 patients/carers did not always carry their adrenaline autoinjectors.A history of anaphylaxis did not ensure compliance, highlighting the need for enhanced anaphylaxis education. To the Editor, Rapid administration of intramuscular adrenaline is the gold standard, life‐saving treatment for anaphylaxis [1, 2, 3]. Guidelines strongly recommend prescription of adrenaline autoinjectors (AAI) for at‐risk patients [1, 2]. Despite an increase in AAI prescriptions in line with these recommendations, fatalities from anaphylaxis continue to occur in the community, often attributable to adrenaline administration delays from patients not carrying their AAI [3]. There remains limited data on the efficacy of AAI during anaphylaxis [3]. For this paper, anaphylaxis is defined as per the World Allergy Organization (WAO) definition [1]. Previous studies identified suboptimal rates of AAI carriage (44%–67%) in various countries, including USA [4], Netherlands [5] and Australia [6]. Reasons for not carrying an AAI included patients forgetting to carry their AAI, belief that they are unlikely to be exposed to the allergen [7], limited availability of AAI [8], and parental anxiety in injecting their children [9]. The latest Australian data from 2017 explored rates of AAI carriage in young adolescents (10–14 years) [6], with wider paediatric and adult data lacking. Our audit sought to obtain local data on AAI carriage rates and related barriers in a mixed paediatric and adult setting. All patients or carers of patients (carers), who had been prescribed an AAI consented to complete a survey during their routine outpatient allergy clinic visit at an Australian metropolitan tertiary hospital from May 2024 to August 2025. A full list of questions is available online (see data availability statement). Besides demographics, patients were surveyed for AAI carriage habits and reasons for non‐carriage if individuals did not always carry their AAI. This audit was approved as a quality improvement initiative with formal ethics approval waived. Statistical comparison was performed using Fisher's Exact test (MedCalc, version 23.3.7). A total of 152 patients/carers responded, comprising 31 adults (≥ 18 years) and 121 children, with a mean age of 13 years (Table 1). An average of 2 devices were carried (Range: 0–6). Fifty‐one percent (n = 78) of respondents reported a history of anaphylaxis, with 27% (n = 21) having been within the last year. 98% of respondents were prescribed an AAI for food allergies, with two respondents for insect allergies and one for drug allergy. TABLE 1Baseline characteristics of the cohort with patterns of and barriers to AAI carriage.AdultChildTotal p Basic statistics n = 31n = 121n = 152Mean Age (Range)30.9 (18–58)7.8 (0–17)12.5 (0–18)Median Age26710Female sex19 (61%)40 (33%)59 (39%) p = 0.007 Average number of AAI (Range)2.1 (1–4)2.2 (0–6)2.2 (0–6)AAI currently in‐date28 (90%)109 (90%)137 (90%) p = 1.00 AAI Carriage (Circumstances) Adult (n = 31) Child (n = 121) Total (n = 152) a Report that they carry their AAI ‘all the time’21 (68%)63 (52%)84 (55%) p = 0.16 For those who did not carry their AAI ‘all the time’ (can select multiple options) Adult (n = 10) Child (n = 58) Total (n = 68) When there are plans to eat9 (90%)25 (43%)34 (50%) p = 0.013 Travelling away from home for extended periods (day trips/camps/holidays etc.)8 (80%)42 (72%)50 (74%) p = 1.00To work/school3 (30%)28 (48%)31 (46%) p = 0.33To extracurricular activitiesN/A12 (21%)12 (18%)N/ADon't normally carry it0 (0%)6 (10%)6 (9%) p = 0.58 For those who did not carry their AAI ‘all the time’ Adult (n = 10) Child (n = 58) Total (n = 68) Prior history of anaphylaxis5 (50%)21 (36%)26 (38%) p = 0.49Prior history of anaphylaxis within the past year1 (10%)6 (10%)7 (10%) p = 1.00 AAI Carriage (Day of Appointment) Carried their AAI to the clinic appointment on day of survey25 (81%)82 (68%)107 (70%) p = 0.19Did not carry their AAI to the clinic appointment on day of survey6 (19%)39 (32%)45 (30%) p = 0.19 For those who did not carry their AAI, (can select multiple options) Adult (n = 6) Child (n = 39) Total (n = 45) a Main barrier cited as Forgot3 (50%)19 (49%)22 (49%) p = 1.00Main barrier cited as Don't think it's needed1 (17%)16 (41%)17 (38%) p = 0.38Main barrier cited as Never had anaphylaxis2 (33%)8 (21%)10 (22%) p = 0.60Main barrier cited as Too big2 (33%)2 (5%)4 (8%) p = 0.08 For those who did not carry their AAI Adult (n = 6) Child (n = 39) Total (n = 45) a Prior history of anaphylaxis2 (33%)16 (41%)18 (40%) p = 1.00Prior history of anaphylaxis within the past year1 (17%)5 (13%)6 (13%) p = 1.00 Note: Bold p values indicate statistical significant (p < 0.05). a All Fisher's Exact tests were calculated as ‘named item’ versus ‘all other items grouped as a single group’ for ‘adult’ and ‘child’ groups. Baseline characteristics of the cohort with patterns of and barriers to AAI carriage. Note: Bold p values indicate statistical significant (p < 0.05). All Fisher's Exact tests were calculated as ‘named item’ versus ‘all other items grouped as a single group’ for ‘adult’ and ‘child’ groups. Regarding AAI carriage frequency, only 55% (n = 84) reported that they always carry their AAI (Table 1). Adults (68%) and carers of preschool children (62%) were more likely to always carry an AAI, compared to carers of primary school (48%) and high school (46%) children (p = 0.035). Respondents who did not always carry their AAI were asked to select all circumstances where they would carry their AAI; 74% carried their AAI when travelling away from home for extended periods (such as day trips/holidays), 50% only when there were plans to eat, and 46% when going to work or school. Concerningly, six carers (10%) stated they did not routinely carry their child's AAI at all. Of the 68 respondents who did not always carry an AAI, 38% (n = 26) reported a history of previous anaphylaxis, with 27% (n = 7) of them having been within the last year. While all adults (n = 5) within this cohort reported carrying their AAI when they had plans to eat, only 33% (n = 7) of paediatric carers reported the same (p = 0.013). Seventy percent (n = 107, adult = 25, paediatric = 82) brought their AAI to their appointment. Among the 45 respondents that did not do so, reasons provided included forgetting it (49%), perception that an AAI was not needed (38%), and no previous history of anaphylactic reactions (22%). Eight percent (n = 4) cited the device being too big as a barrier. Of those who did not carry their AAI on the day of the clinic visit, 40% (n = 18) reported a prior history of anaphylaxis, with a third of them (n = 6) having had anaphylaxis within the last year. Reassuringly, 93% (n = 142) of respondents were either ‘somewhat’ or ‘very’ confident in using the AAI in emergencies. Those who had previous experience in using an AAI were more likely to report being ‘very confident’ in administering the AAI (72% vs. 38%, p < 0.001). When asked about knowledge of local allergy resources, 31% of respondents (n = 47) were not aware of any of the nine resources listed. There are several limitations to this audit. Firstly, we did not explore the severity of previous anaphylaxis, and anaphylaxis was not explicitly defined in the survey but based on respondents' own understanding. Confidence in using AAI was a self‐reported measure rather than by directly evaluating administration technique. Furthermore, our cross‐sectional data was obtained from a single urban centre, limiting generalisability of findings. In summary, despite clear guidelines recommending early access to AAI for patients at risk of anaphylaxis [1, 2], our data demonstrate that only about half the respondents consistently carried their device. These findings align with broader overseas literature [4, 5] and the last Australian adolescent study conducted nearly a decade ago [6]. Notably, a history of anaphylaxis did not guarantee adherence to AAI carriage. The awareness of educational resources appeared limited despite much effort having been put into their development. While these findings may not be entirely novel, they underscore a persistent and troubling reality: young lives continue to be lost despite a multitude of interventions—including food‐labelling legislation, AAI prescription guidelines, and food allergen management training in food service industries. By providing current, population‐level data, our study highlights the enduring severity of the challenges associated with preventing anaphylaxis and reinforces the need for ongoing intervention to improve AAI carriage, address misconceptions, and empower patients and carers. Author Contributions J.C.L., Y.T.V.A., S.L.F. and S.S. conceptualised the study. All authors provided input to the survey design. J.C.L., Y.T.V.A., R.Z., T.B. and S.S. recruited participants for the study. J.C.L., Y.T.V.A., S.L.F. and S.S. performed data analysis. J.C.L., Y.T.V.A., S.L.F. and S.S. were involved in the preparation of the original draft of the manuscript. All authors provided input and further editing of the manuscript. Funding The authors have nothing to report. Ethics Statement This project was approved as a quality improvement initiative by the Royal North Shore Hospital Medical Services under project number RNSH QIP‐17‐2024 with formal ethics approval waived. Conflicts of Interest The authors declare no conflicts of interest.